Bayer Raises Consumer Health Guidance Following Double-Digit Gain In Q2
Executive Summary
Bayer believes its Consumer Health business has the potential to grow at twice the rate of the global market in 2021 following a double-digit rise in sales in the second quarter.
You may also be interested in...
Successful Innovation And Supplement Gains Drive 'Exceptional' Q3 For Bayer
Successful launches and increased demand for dietary supplements helped to drive up Bayer's Consumer Health's sales double-digits in Q3. As a consequence, the German firm has raised its 2021 sales guidance for Consumer Health for the second time so far this year.
Euro Q3 Consumer Health Earnings Preview: GSK, Sanofi, Bayer And Reckitt
Major Europe-based consumer health players GSK, Sanofi, Bayer and Reckitt continue to deal with the fallout of the COVID-19 pandemic while implementing long-term strategies to drive growth. This earnings preview highlights what to look out for as these four firms report their third-quarter results over the coming weeks.
Bayer Spreads Aleve Brand Into Topical Pain Relief
Three-product AleveX line contains menthol and camphor for minor muscle and joints aches and pains with a cooling sensation. Bayer Healthcare promotes launch with an ad campaign featuring basketball legend and TV personality Charles Barkley.